Intervention

Computed tomography (CT)

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions6

Lead sponsors shown3

Clinical trials

3 shown

Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast CancerNCT04504331 · 2020-10-13

Assessment of Bronchial Thickness Using MRI in AsthmaNCT03089346 · 2017-05-05

Evaluation of the Effectiveness of Non-invasive Ventilation on the Reperfusion Pulmonary Edema Post Pulmonary Artery Angioplasty in the Post Embolic Pulmonary HypertensionNCT02548091 · 2016-02-01

Common conditions

Asthma1 Breast Cancer1 ER Positive Breast Cancer1 HER2-negative Breast Cancer1 PR-Positive Breast Cancer1 Reperfusion Pulmonary Edema1

Leading sponsors

Centre Chirurgical Marie Lannelongue1 Jennifer Lee Caswell-Jin1 University Hospital, Bordeaux1

Trial status mix

COMPLETED1

TERMINATED1

UNKNOWN1

Phase mix

NA2

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.